Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Frontiers in Immunology
|
August 30, 2024
Targeting amino acid-metabolizing enzymes for cancer immunotherapy
Yvonne Grobben
Cancers
|
February 11, 2023
Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1
Yvonne Grobben, Judith E den Ouden, Cristina Aguado, et al.
Bioconjugate Chemistry
|
February 23, 2019
Installation of Trimethyllysine Analogs on Intact Histones via Cysteine Alkylation
Bas J G E Pieters, Jordi C J Hintzen, Yvonne Grobben, et al.
Journal of Structural Biology: X
|
July 11, 2020
Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158
Yvonne Grobben, Joost C M Uitdehaag, Nicole Willemsen-Seegers, et al.
Journal of Natural Products
|
July 4, 2025
Synthesis and Absolute Configuration of the Sesquiterpene Lactone EPD, a Natural Product with Broad Antitumor Cell Activity via a Unique Mechanism of Action
Caroline van Haaften, Jan Koek, Jaap D H van Eendenburg, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 19, 2020
High-Throughput Fluorescence-Based Activity Assay for Arginase-1
Yvonne Grobben, Nicole Willemsen-Seegers, Joost C M Uitdehaag, et al.
Oncotarget
|
December 21, 2020
Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
Judith E den Ouden, Guido J R Zaman, Jelle Dylus, et al.
Frontiers in Oncology
|
November 7, 2025
Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers
Daphne J F Kluitmans, Janneke J T M Melis, Esmee van den Bossche, et al.
Frontiers in Oncology
|
October 3, 2022
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020
Jeffrey J Kooijman, Wilhelmina E van Riel, Jelle Dylus, et al.
The FEBS Journal
|
January 20, 2021
Pharmacological validation of TDO as a target for Parkinson's disease
Paula Perez-Pardo, Yvonne Grobben, Nicole Willemsen-Seegers, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Frontiers in Immunology
|
August 30, 2024
Targeting amino acid-metabolizing enzymes for cancer immunotherapy
Yvonne Grobben
Cancers
|
February 11, 2023
Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1
Yvonne Grobben, Judith E den Ouden, Cristina Aguado, et al.
Bioconjugate Chemistry
|
February 23, 2019
Installation of Trimethyllysine Analogs on Intact Histones via Cysteine Alkylation
Bas J G E Pieters, Jordi C J Hintzen, Yvonne Grobben, et al.
Journal of Structural Biology: X
|
July 11, 2020
Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158
Yvonne Grobben, Joost C M Uitdehaag, Nicole Willemsen-Seegers, et al.
Journal of Natural Products
|
July 4, 2025
Synthesis and Absolute Configuration of the Sesquiterpene Lactone EPD, a Natural Product with Broad Antitumor Cell Activity via a Unique Mechanism of Action
Caroline van Haaften, Jan Koek, Jaap D H van Eendenburg, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 19, 2020
High-Throughput Fluorescence-Based Activity Assay for Arginase-1
Yvonne Grobben, Nicole Willemsen-Seegers, Joost C M Uitdehaag, et al.
Oncotarget
|
December 21, 2020
Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
Judith E den Ouden, Guido J R Zaman, Jelle Dylus, et al.
Frontiers in Oncology
|
November 7, 2025
Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers
Daphne J F Kluitmans, Janneke J T M Melis, Esmee van den Bossche, et al.
Frontiers in Oncology
|
October 3, 2022
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020
Jeffrey J Kooijman, Wilhelmina E van Riel, Jelle Dylus, et al.
The FEBS Journal
|
January 20, 2021
Pharmacological validation of TDO as a target for Parkinson's disease
Paula Perez-Pardo, Yvonne Grobben, Nicole Willemsen-Seegers, et al.
Page
of 2